Following the outbreak, there is usually much interest in continued research and data analyses on the materials gathered. Research priorities should be developed by giving equal consideration to all of the international partners to avoid dissension over proprietary rights to clinical materials and authorship of publications. “Smart partnership” requires total trust and transparency in all aspects of the investigation; there should be no hidden agendas. Open communication should be established and misunderstandings ironed out to prevent frustration and unwarranted accusation.
In summary, emerging infection is something we have to live with for years to come. Developing countries usually serve as the epicenter, and yet they are not equipped to handle outbreak investigation without international assistance. Such investigations must be conducted in a “smart partnership” agreement to promote cooperation to achieve public health.